BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37809092)

  • 1. Potential drug targets for asthma identified in the plasma and brain through Mendelian randomization analysis.
    Wang Y; Wang J; Yan Z; Liu S; Xu W
    Front Immunol; 2023; 14():1240517. PubMed ID: 37809092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis.
    Lin J; Zhou J; Xu Y
    Brain; 2023 Aug; 146(8):3364-3372. PubMed ID: 36864689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential drug targets for allergic diseases from a genetic perspective: A mendelian randomization study.
    Wang H; Pang J; Zhou Y; Qi Q; Tang Y; Gul S; Sheng M; Dan J; Tang W
    Clin Transl Allergy; 2024 Apr; 14(4):e12350. PubMed ID: 38573314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening.
    Yuan W; Xu W; Xu X; Qu B; Zhao F
    Sci Rep; 2024 May; 14(1):11726. PubMed ID: 38778174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential therapeutic targets for membranous nephropathy: proteome-wide Mendelian randomization and colocalization analysis.
    Su Z; Wan Q
    Front Immunol; 2024; 15():1342912. PubMed ID: 38707900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promising therapeutic targets for ischemic stroke identified from plasma and cerebrospinal fluid proteomes: a multicenter Mendelian randomization study.
    Zou X; Wang L; Wang S; Zhang Y; Ma J; Chen L; Li Y; Yao TX; Zhou H; Wu L; Tang Q; Ma S; Zhang X; Tang R; Yi Y; Liu R; Zeng Y; Zhang L
    Int J Surg; 2024 Feb; 110(2):766-776. PubMed ID: 38016292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential drug targets for insomnia by Mendelian randomization analysis based on plasma proteomics.
    Yang N; Shi L; Xu P; Ren F; Lv S; Li C; Qi X
    Front Neurol; 2024; 15():1380321. PubMed ID: 38725646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
    Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
    J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying novel proteins for migraine by integrating proteomes from blood and CSF with genome-wide association data.
    Niu PP; Zhang R; Zhang C; Li S; Li YS
    CNS Neurosci Ther; 2024 Jun; 30(6):e14817. PubMed ID: 38898596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into telomere regulation: road to discovery and intervention in plasma drug-protein targets.
    Ding K; Zhangwang J; Lei M; Xiong C
    BMC Genomics; 2024 Mar; 25(1):231. PubMed ID: 38431573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential drug targets for myocardial infarction identified through Mendelian randomization analysis and Genetic colocalization.
    Wu J; Fan Q; He Q; Zhong Q; Zhu X; Cai H; He X; Xu Y; Huang Y; Di X
    Medicine (Baltimore); 2023 Dec; 102(49):e36284. PubMed ID: 38065874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential drug targets for tumors identified through Mendelian randomization analysis.
    Song N; Shi P; Cui K; Zeng L; Wang Z; Di W; Li J; Fan Y; Li Z; Zhang J; Su W; Wang H
    Sci Rep; 2024 May; 14(1):11370. PubMed ID: 38762700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the genetic association of allergic diseases with cardiovascular diseases: a bidirectional Mendelian randomization study.
    Wang S; Liu H; Yang P; Wang Z; Hu P; Ye P; Xia J; Chen S
    Front Immunol; 2023; 14():1175890. PubMed ID: 37334359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers.
    Ren F; Jin Q; Liu T; Ren X; Zhan Y
    J Transl Med; 2023 Sep; 21(1):646. PubMed ID: 37735436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causal relationships of metabolites with allergic diseases: a trans-ethnic Mendelian randomization study.
    Tu J; Wen J; Luo Q; Li X; Wang D; Ye J
    Respir Res; 2024 Feb; 25(1):94. PubMed ID: 38378549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of plasma protein markers of allergic disease risk: a mendelian randomization approach to proteomic analysis.
    Cao Z; Li Q; Li Y; Wu J
    BMC Genomics; 2024 May; 25(1):503. PubMed ID: 38773393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association Between Insulin Use and Asthma: An Epidemiological Observational Analysis and Mendelian Randomization Study.
    Lin Z; Huang J; Xie S; Zheng Z; Tang K; Li S; Chen R
    Lung; 2023 Apr; 201(2):189-199. PubMed ID: 36971839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma adiponectin and risk of asthma: observational analysis, genetic Mendelian randomisation and meta-analysis.
    Nielsen MB; Nordestgaard BG; Benn M; Çolak Y
    Thorax; 2022 Nov; 77(11):1070-1077. PubMed ID: 34949725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mendelian randomization study shows a causal effect of asthma on epilepsy risk.
    Tang P; Guo X; Chong L; Li R
    Front Immunol; 2023; 14():1071580. PubMed ID: 36860869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prospective aging drug targets via Mendelian randomization analysis.
    Mao R; Li J; Xiao W
    Aging Cell; 2024 Apr; ():e14171. PubMed ID: 38572516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.